Dermatopathology of Toxic Erythema of Chemotherapy: Comprehensive Approach to Diagnosis and Management

The presentation by Dr. Wen focuses on the dermatopathology of Toxic Erythema of Chemotherapy (TEC), emphasizing its differentiation from conditions such as graft-versus-host disease (GVHD) and Squamous Cell Carcinoma (SEC). He outlines histopathological features critical for diagnosis, including echrine syringosquamous metaplasia, epidermal dismaturation, and neutrophilic echrine hidradenitis, which can help distinguish TEC from other similar diseases. Dr. Wen discusses the challenge of identifying TEC due to its overlapping features with these conditions, particularly in patients who are immunocompromised. He suggests collaboration with dermatopathologists for detailed examinations, noting that particular features may not be consistently present. The importance of considering clinical findings—the relationship between histological changes and clinical presentations, like hand-foot syndrome—alongside immunological markers such as CD4 and CD8 ratios is also highlighted. The presentation concludes with the recommendation for further studies to refine diagnostic criteria and enhance understanding of TEC and its distinctions from SGSTN and GVHD.